导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.33% | 790/1050 |
| 近一周 | -2.87% | 764/1104 |
| 近一月 | -7.07% | 828/1102 |
| 近一季 | -6.13% | 470/1092 |
| 近半年 | -8.30% | 714/1070 |
| 近一年 | -5.92% | 667/1018 |
| 近两年 | 52.29% | 493/926 |
| 近三年 | 35.52% | 348/834 |
| 成立以来 | 60.07% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.03% 972/1070 |
17.51% 415/1101 |
- - |
- - |
| 2025 | 43.56% 267/1065 |
6.80% 298/1014 |
9.60% 118/1038 |
24.25% 464/1050 |
-1.29% 517/1065 |
| 2024 | 17.44% 126/1011 |
1.56% 229/960 |
6.52% 66/983 |
18.30% 97/991 |
-8.24% 834/1011 |
| 2023 | -21.66% 706/952 |
-1.97% 713/880 |
-9.58% 754/895 |
-3.01% 202/915 |
-8.88% 804/952 |
| 2022 | -10.18% 88/867 |
-11.08% 129/773 |
5.76% 476/806 |
-14.50% 539/845 |
11.71% 55/867 |
| 2021 | 9.03% 261/740 |
14.70% 2/580 |
-2.78% 570/659 |
0.99% 205/704 |
-3.18% 548/740 |
| 2020 | - - |
- - |
- - |
8.66% 281/517 |
11.50% 309/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实基础产业优选股票A VS. 东吴新产业精选股票A(580008) |